IN BRIEF: ImmuPharma to make cost savings as it simplifies structure Read More
EARNINGS UPDATES: Pittards swings to profit; Immupharma loss widens Read More
DIRECTOR DEALINGS: Gamesys, Capital and ActiveOps execs sell shares Read More
IN BRIEF: Immupharma gets US FDA approval for Lupuzor pre-trial study Read More
EXECUTIVE CHANGES: All change for ImmuPharma board as CEO departs Read More
IN BRIEF: ImmuPharma appoints COO Tim Franklin to board of directors Read More
AIM WINNERS & LOSERS: Pantheon up on resource upgrade, farmout talks Read More
IN BRIEF: Immupharma moves step closer to Lupazor phase three trial Read More
UK shareholder meetings calendar - next 7 days Read More
EXECUTIVE CHANGES: Gresham House Strategic plots future as chair exits Read More
TRADING UPDATES: Keystone Law and Checkit post annual revenue growth Read More
AIM WINNERS & LOSERS: Tavistock Rises As Tips Annual Earnings Climb Read More
No Conditional US Approval So Far For ImmuPharma Lupus Drug Lupuzor Read More
UK TRADING UPDATE SUMMARY: Gore Street Energy Energises Drumkee Read More
IN BRIEF: Immupharma Says L1 Capital Converts USD200,000 Of Security Read More
ImmuPharma Partner To Discuss Progression Of Lupuzor Drug With US FDA Read More
UK TRADING UPDATE SUMMARY: Newly-Listed Wheaton Reports Bumper Quarter Read More
UK EARNINGS SUMMARY: Itaconix 2019 Loss Narrows On Strong Revenue Rise Read More
IN BRIEF: Immupharma Raises Stake In Incanthera To 15.4% Read More
IN BRIEF: Immupharma Repays Lind Global Convertible Security Read More
